Linical Co., Ltd.

TSE:2183 Stock Report

Market Cap: JP¥7.8b

Linical Management

Management criteria checks 1/4

Linical's CEO is Kazuhiro Hatano, appointed in Jun 2005, has a tenure of 19.42 years. directly owns 3.29% of the company’s shares, worth ¥255.99M. The average tenure of the management team and the board of directors is 13.3 years and 1.4 years respectively.

Key information

Kazuhiro Hatano

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure19.4yrs
CEO ownership3.3%
Management average tenure13.3yrs
Board average tenure1.4yrs

Recent management updates

Recent updates

Linical's (TSE:2183) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 17
Linical's (TSE:2183) Shareholders Will Receive A Bigger Dividend Than Last Year

There May Be Some Bright Spots In Linical's (TSE:2183) Earnings

May 22
There May Be Some Bright Spots In Linical's (TSE:2183) Earnings

Some Linical Co., Ltd. (TSE:2183) Shareholders Look For Exit As Shares Take 26% Pounding

Mar 08
Some Linical Co., Ltd. (TSE:2183) Shareholders Look For Exit As Shares Take 26% Pounding

Linical (TSE:2183) Is Paying Out A Larger Dividend Than Last Year

Feb 26
Linical (TSE:2183) Is Paying Out A Larger Dividend Than Last Year

CEO

Kazuhiro Hatano (59 yo)

19.4yrs

Tenure

Mr. Kazuhiro Hatano has been the Chief Executive Officer and Director at Linical Co. Ltd. since June 2005, serves as its Chief Strategy Officer since August 2024, serves as its Chief Commercial Officer and...

Leadership Team

NamePositionTenureCompensationOwnership
Kazuhiro Hatano
President19.4yrsno data3.29%
¥ 256.0m
Akihiro Takahashi
Chief Financial Officer17.6yrsno data12.11%
¥ 943.6m
Tokuno Masayoshi
Chief Information Officerless than a yearno datano data
Jun Kawai
Chief Administrative Officerless than a yearno data2.66%
¥ 207.0m
Shiori Yamaguchi
Chief Compliance Officer17.4yrsno data0.35%
¥ 27.6m
Keigo Tsujimoto
Executive Officer & Chief Project Officer13.3yrsno data4.53%
¥ 353.3m
Masaya Miyazaki
Chief Asia Pacific Officer17.6yrsno data2.66%
¥ 207.0m
Clareece West
President & Chief Commercial Officer of Americas & Europeless than a yearno datano data
Tracy Goeken
Chief Medical Officerno datano datano data
Satoru Toyota
Executive Officer & Head of Oncology Business Unit (HQno datano datano data
Tomoko Inomata
Executive Officer & Head of Primary Business Unit (HQno datano datano data
Jihoon Hwang
President & CEO of Linical Korea5.8yrsno datano data

13.3yrs

Average Tenure

56.5yo

Average Age

Experienced Management: 2183's management team is seasoned and experienced (13.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Kazuhiro Hatano
President19.4yrsno data3.29%
¥ 256.0m
Kyoichi Shimomura
Independent Outside Director1.4yrsno datano data
Eri Sugiyama
Independent Outside Director1.4yrsno datano data
Yoshiaki Nakashima
Independent Outside Director1.4yrsno datano data
Yuichi Murakami
Independent Outside Director1.4yrsno datano data
Yoshimitsu Ando
Independent Outside Director1.4yrsno datano data
Satoko Nishimura
Independent Outside Director1.4yrsno datano data

1.4yrs

Average Tenure

66yo

Average Age

Experienced Board: 2183's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.